Crypto Pills

Cboe plans to introduce U.S.-listed Bitcoin and Ethereum futures with maturities dated out to 10 years, extending the crypto derivatives curve well beyond current offerings. The move aims to provide longer‑dated hedging and price discovery tools for institutions and professional traders seeking exposure across a broader time horizon.

XRP falls back after a failed breakout above $3, leaving the token below a key round-number threshold following heightened volatility. The pullback prompts reassessment of momentum as traders watch for stabilization and liquidity around recent ranges.

Grayscale seeks approval from the U.S. Securities and Exchange Commission to launch exchange‑traded funds tied to Bitcoin Cash (BCH) and Hedera (HBAR). The filings would expand regulated access to altcoin exposure for investors beyond the firm’s flagship Bitcoin and Ethereum products.

A Dogecoin ETF is set to launch in the United States, positioning itself as the first U.S. fund to hold an asset characterized as having “no utility.” The product brings a meme‑coin into a regulated fund wrapper, signaling mainstream investor access to DOGE via traditional brokerage accounts.

An employment data revision removes about $60 billion from the total cryptocurrency market capitalization, triggering broad declines across major tokens. The update prompts a swift risk‑off move as traders reduce exposure and adjust to the new macro signal.